Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q1 2024 · 10-Q
Revenue$717.40M$717.40M+7.7% vs Q1 2023 Net Income-$12.40M-$12.40MN/M vs Q1 2023 EPS Diluted-$0.10-$0.10N/M vs Q1 2023 Operating Income$76,000,000+63.8% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
Free Cash Flowderived$19,700,000−60.8% Margins · derivedOperating margin10.6%+3.6 pt vs Q1 2023
Net margin-1.7%+2.0 pt vs Q1 2023
ended Mar 31, 2024 · filed May 7, 2024 · 37 d after period end